Clinical trials

The European Union Clinical Trials Register allows you to search for protocol and results information on:

interventional clinical trials that were approved in the European Union (EU)/European Economic Area (EEA) under the Clinical Trials Directive 2001/20/EC

clinical trials conducted outside the EU/EEA that are linked to European paediatric-medicine development

EU/EEA interventional clinical trials approved under or transitioned to the Clinical Trial Regulation 536/2014 are publicly accessible through the
Clinical Trials Information System (CTIS).

The EU Clinical Trials Register currently displays 44380 clinical trials with a EudraCT protocol, of which 7392 are clinical trials conducted with subjects less than 18 years old. The register also displays information on 18700 older paediatric trials (in scope of Article 45 of the Paediatric Regulation (EC) No 1901/2006).

Phase 1 trials conducted solely on adults and that are not part of an agreed paediatric investigation plan (PIP) are not publicly available (see Frequently Asked Questions ).

Examples: Cancer AND drug name. Pneumonia AND sponsor name.
How to search [pdf]

Advanced Search:

Search tools

Select Country:	Select Age Range:
Select Trial Status:	Select Trial Phase:
Select Gender:
Select Date Range: to
Select Rare Disease:
IMP with orphan designation in the indication
Orphan Designation Number:
Results Status:
Clear advanced search filters

Trials with a EudraCT protocol (44,380)
Paediatric studies in scope of Art45 of the Paediatric Regulation (0)

44,380 result(s) found. Displaying page 70 of 2,219.

EudraCT Number: 2009-015589-74

Sponsor Protocol Number: NYC-IBU-1

Start Date*: 2009-10-02

Sponsor Name:Nycomed Sweden Holding 2 AB

Full Title: A controlled, randomized, double-blind, cross-over study of the onset of analgesic effect of two formulations of ibuprofen for the treatment of pain after oral surgery.

Medical condition: Pain

Disease:	Version	SOC Term	Classification Code	Term	Level
Disease:	12.0		10033371	Pain	LLT

Population Age: Adults

Gender: Male, Female

Trial protocol: SE (Completed) DK (Completed)

Trial results: View results

EudraCT Number: 2006-006436-22

Sponsor Protocol Number: BAY a 1040 - BAY 68-9291/12313

Start Date*: 2007-08-29

Sponsor Name:BAYER

Full Title: A multicenter Study Evaluating the Efficacy of Nifedipine GITS ﾖ Telmisartan Combination in Blood Pressure Control and Beyond: comparison of two strategies.

Medical condition: Hypertension

Disease:	Version	SOC Term	Classification Code	Term	Level
Disease:	6.1		10020772		PT

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: IT (Completed) ES (Completed)

Trial results: View results

EudraCT Number: 2006-006439-39	Sponsor Protocol Number: Packat ver 5	Start Date*: 2007-04-25
Sponsor Name:Lund University Hospital
Full Title: Bisfosfonatbehandling av bentransplantat vid höftrevisionhöftplastikrevision utvärderat med radiostereofotogrametri. En randomiserad, dubbel-blind studie hos patienter opererade för osteolys och as...
Medical condition: Revision of hip prostheses with osteolysis
Disease:
Population Age: Adults, Elderly		Gender: Male, Female
Trial protocol: SE (Completed)
Trial results: (No results available)

EudraCT Number: 2006-006441-14

Sponsor Protocol Number: CRIT124DDE04

Start Date*: 2007-04-18

Sponsor Name:Novartis Pharma GmbH

Full Title: A randomized, rater-blinded cross-over multicenter study comparing the clinical efficacy of Ritalin® LA (methylphenidate) treatment (20 or 40 mg orally o.d.) in children with ADHD under different b...

Medical condition: attention deficit hyperactivity disorder (ADHD)

Disease:	Version	SOC Term	Classification Code	Term	Level
Disease:	9.1		10064104	ADHD	LLT

Population Age: Children, Adolescents, Under 18

Gender: Male, Female

Trial protocol: DE (Completed)

Trial results: View results

EudraCT Number: 2008-002628-27

Sponsor Protocol Number: CAIN457A2206

Start Date*: 2009-01-15

Sponsor Name:Novartis Pharma Services AG

Full Title: Randomized, double-blind, placebo-controlled, multi-center, proof-of-concept study to assess the efficacy of AIN457 in patients with psoriatic arthritis

Medical condition: Psoriatic arthritis (PsA), which belongs to seronegative spondyloarthropathies (SpA).

Disease:	Version	SOC Term	Classification Code	Term	Level
Disease:	9.1		10037160	Psoriatic arthritis	LLT

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: GB (Prematurely Ended) DE (Prematurely Ended) NL (Prematurely Ended)

Trial results: View results

EudraCT Number: 2008-002655-24

Sponsor Protocol Number: SMR-1850/2PX-SP-02

Start Date*: 2008-09-30

Sponsor Name:SantoSolve A/S

Full Title: A randomised, double-blind, placebo (vehicle) controlled, parallel group study of the efficacy, safety and tolerability of topical 2PX (strontium chloride hexahydrate) in patients with chronic, mod...

Medical condition: Post amputation patients (at least 6 months prior to visit 1) with chronic moderate-to-severe lower limb stump pain, defined as average stump pain on a daily basis (≥40 on a 100 mm pain VAS scale) ...

Disease:	Version	SOC Term	Classification Code	Term	Level
Disease:	9.1		10023931	Late amputation stump complication	LLT

Population Age:

Gender: Male, Female

Trial protocol: DK (Completed) GB (Prematurely Ended) DE (Completed)

Trial results: (No results available)

EudraCT Number: 2007-007580-24	Sponsor Protocol Number: EB70	Start Date*: 2008-02-08
Sponsor Name:Emotional Brain
Full Title: A double blind, randomized, 3-arm placebo controlled study to investigate the subjective and physiological efficacy and safety of Lybrido and Lybridos in the domestic setting in healthy female subj...
Medical condition: Hypoactive sexual desire disorder and female sexual arousal disorder
Disease:
Population Age: Adults		Gender: Female
Trial protocol: NL (Completed)
Trial results: (No results available)

EudraCT Number: 2007-007591-42

Sponsor Protocol Number: SPON416-07(WCTU011)

Start Date*: 2009-01-14

Sponsor Name:Cardiff University

Full Title: A Phase II single-arm trial to evaluate cisplatin and gemcitabine chemotherapy in combination with sunitinib for first-line treatment of patients with advancd transitional carcinoma of the urothelium.

Medical condition: Advanced transitional cell carcinoma of the urothelium.

Disease:	Version	SOC Term	Classification Code	Term	Level
	9.1		10005003	Bladder cancer	LLT
	9.1		10038517	Renal pelvis cancer NOS	LLT
	9.1		10046375	Ureter cancer	LLT

Population Age: Adolescents, Under 18, Adults, Elderly

Gender: Male, Female

Trial protocol: GB (Completed)

Trial results: View results

EudraCT Number: 2007-007593-31	Sponsor Protocol Number: prot 122	Start Date*: 2008-11-21
Sponsor Name:FONDAZIONE RICERCA TRAPIANTO DI MIDOLLO OSSEO
Full Title: Thiotepa dose finding study for allogeneic SCT in adult patients with high risk haematological malignancies
Medical condition: bone marrow transplantation
Disease:
Population Age: Adults, Elderly		Gender: Male, Female
Trial protocol: IT (Ongoing)
Trial results: (No results available)

EudraCT Number: 2007-007604-15

Sponsor Protocol Number: STH14971

Start Date*: 2009-03-03

Sponsor Name:Sheffield Teaching Hospitals NHS Foundation Trust

Full Title: A Pilot Study of the Effect of Glucocorticoid Receptor Antagonism in Patients with Sub-Clinical Cushing's Syndrome

Medical condition: Sub Clinical Cushing's Syndrome

Disease:	Version	SOC Term	Classification Code	Term	Level
Disease:	9.1		10011652	Cushing's syndrome	PT

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: GB (Completed)

Trial results: View results

EudraCT Number: 2007-007623-40

Sponsor Protocol Number: D4320C00035

Start Date*: 2008-09-05

Sponsor Name:AstraZeneca AB

Full Title: A Phase II, Double-blind, Placebo-Controlled, Randomised Study to Assess the Efficacy and Safety of ZD4054 in Combination with Pemetrexed (Alimta®) vs. Pemetrexed Alone in Patients with Non-small C...

Medical condition: Locally advanced or metastatic Non small cell lung cancer (NSCLC) without predominantly squamous cell histology

Disease:	Version	SOC Term	Classification Code	Term	Level
Disease:	9.1		10066490	Progression of non small cell lung cancer	LLT

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: FR (Ongoing) CZ (Completed) BG (Completed)

Trial results: (No results available)

EudraCT Number: 2008-001201-42

Sponsor Protocol Number: 4-001-LVS

Start Date*: 2008-06-01

Sponsor Name:POLICLINICO SAN DONATO IRCSS

Full Title: Clinical trial on the use of ivabradine in patients with inappropriate sinus tachycardia

Medical condition: Inappropriate sinus tachycardia

Disease:	Version	SOC Term	Classification Code	Term	Level
Disease:	9.1		10003133	Arrythmia sinus	LLT

Population Age: Adolescents, Under 18, Adults, Elderly

Gender: Male, Female

Trial protocol: IT (Ongoing)

Trial results: (No results available)

EudraCT Number: 2008-001226-14

Sponsor Protocol Number: 3207-005

Start Date*: 2008-07-25

Sponsor Name:Merck Sharp & Dohme (Sweden) AB

Full Title: A Phase IIb, Multicenter, Randomized, Double-Blind, Placebo- Controlled, Dose-Finding Study of MK-3207 in the Treatment of Acute Migraine

Medical condition: migraine

Disease:	Version	SOC Term	Classification Code	Term	Level
Disease:	9.1		10027599	Migraine	LLT

Population Age: Adults

Gender: Male, Female

Trial protocol: SE (Completed) BE (Completed) DE (Completed) IT (Completed)

Trial results: View results

EudraCT Number: 2008-001236-13

Sponsor Protocol Number: 2008-001236-13

Start Date*: 2007-12-01

Sponsor Name:AZIENDA OSPEDALIERA DI PADOVA

Full Title: Sperimental controlled and randomized in singol blind study. Use of continuous epidural ketamina in patients submitted to toracotomy for pulmonary resection.

Medical condition: pulmonary resection

Disease:	Version	SOC Term	Classification Code	Term	Level
Disease:	9.1		10038738		SOC

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: IT (Ongoing)

Trial results: (No results available)

EudraCT Number: 2009-014286-20

Sponsor Protocol Number: AGTC-AAT-002

Start Date*: 2010-12-21

Sponsor Name:Applied Genetic Technologies Corporation

Full Title: A Multiple-Site, Phase 2, Safety and Efficacy Trial of a Recombinant Adeno-associated Virus Vector Expressing Alpha 1 Antitrypsin (rAAV1-CB-hAAT) in Patients with Alpha 1 Antitrypsin Deficiency

Medical condition: Alpha 1 antitrypsin deficiency.This is an inherited, genetic condition characterized by reduced serum levels of alpha-1 antitrypsin (AAT) which increases the risk of developing emphysema and liver ...

Disease:	Version	SOC Term	Classification Code	Term	Level
Disease:	12.1		10001806	Alpha-1 anti-trypsin deficiency	PT

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: IE (Completed)

Trial results: View results

EudraCT Number: 2008-007507-83

Sponsor Protocol Number: CRAD001AIT12

Start Date*: 2009-03-18

Sponsor Name:NOVARTIS FARMA

Full Title: Once-a-day regimen or Steroid withdrawal in de novo kidney transplant recipients treated with everolimus, cyclosporin and steroids: a 12-month, prospective, randomized, multicenter, open-label stud...

Medical condition: Recipients of a de novo kidney transplant.

Disease:	Version	SOC Term	Classification Code	Term	Level
Disease:	9.1		10023438	Kidney transplant	LLT

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: IT (Completed)

Trial results: View results

EudraCT Number: 2008-007520-26

Sponsor Protocol Number: PROSPERA (Rasagiline)

Start Date*: 2010-06-24

Sponsor Name:Klinikum der Universität München

Full Title: A Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study to assess the Efficacy, Tolerability and Safety of Rasagiline in Subjects with Progressive Supranuclear Palsy (Phase III)

Medical condition: Progressive Supranuclear Palsy

Disease:	Version	SOC Term	Classification Code	Term	Level
Disease:	12.0		10036813	Progressive supranuclear palsy	PT

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: DE (Prematurely Ended)

Trial results: (No results available)

EudraCT Number: 2009-011585-28

Sponsor Protocol Number: BGC20-0134-02

Start Date*: 2009-10-08

Sponsor Name:BTG International Ltd

Full Title: A randomised double-blind placebo-controlled phase IIa study of orally administered BGC20-0134 in patients with relapsing-remitting multiple sclerosis (RRMS)

Medical condition: relapsing-remitting multiple sclerosis

Disease:	Version	SOC Term	Classification Code	Term	Level
Disease:	14.0	10029205 - Nervous system disorders	10063399	Relapsing-remitting multiple sclerosis	PT

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: DE (Prematurely Ended) BE (Prematurely Ended) FR (Ongoing) ES (Prematurely Ended)

Trial results: (No results available)

EudraCT Number: 2009-011589-27

Sponsor Protocol Number: S337.2.001

Start Date*: 2009-09-01

Sponsor Name:Laboratoires Fournier S.A. A Solvay Pharmaceuticals company

Full Title: A Double-blind, Randomized, Placebo-controlled, Parallel Group Study to Assess Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of SLV337 in Patients with Type 2 Diabetes on Metformin Mo...

Medical condition: Type 2 diabetes mellitus (T2DM)

Disease:	Version	SOC Term	Classification Code	Term	Level
Disease:	12.0		10067585		LLT

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: PL (Completed) BG (Completed)

Trial results: View results

EudraCT Number: 2010-023008-29	Sponsor Protocol Number: FH-10	Start Date*: 2011-01-12
Sponsor Name:Fundación Huésped
Full Title: Estudio Fase 3, Aleatorizado, Abierto, Controlado de Lopinavir/Ritonavir y Lamivudina versus terapia estándar en Pacientes Infectados con HIV-1 Naïve.
Medical condition: El propósito del estudio es comparar la seguridad y la eficacia de la combinación de Lopinavir/Ritonavir más 3TC versus terapia estándar con 2 INTIs y Lopinavir/Ritonavir en pacientes infectados co...
Disease:
Population Age: Adults		Gender: Male, Female
Trial protocol: ES (Completed)
Trial results: (No results available)

Subscribe to this Search
To subscribe to the RSS feed for this search click here

. This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.

Download Options:
Number of Trials to download:

Download Content:

Download Format:


Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial.

Query did not match any studies.

For support, Contact us.

The status and protocol content of GB trials is no longer updated since 1 January 2021. For the UK, as of 31 January 2021, EU Law applies only to the territory of Northern Ireland (NI) to the extent foreseen in the Protocol on Ireland/NI. Legal notice
As of 31 January 2023, all EU/EEA initial clinical trial applications must be submitted through CTIS . Updated EudraCT trials information and information on PIP/Art 46 trials conducted exclusively in third countries continues to be submitted through EudraCT and published on this website.

European Medicines Agency © 1995-Tue Feb 10 04:41:15 CET 2026 | Domenico Scarlattilaan 6, 1083 HS Amsterdam, The Netherlands

Austria
Belgium
Bulgaria
Croatia
Cyprus
Czechia
Denmark
Estonia
Finland
France
Germany
Greece
Hungary
Iceland
Ireland
Italy
Latvia
Liechtenstein
Lithuania
Luxembourg
Malta
Netherlands
Norway
Poland
Portugal
Romania
Slovakia
Slovenia
Spain
Sweden
United Kingdom
Outside EU/EEA